Fourteen scientists from St. Jude Children’s Research Hospital are among the investigators named to the 2022 list of Highly Cited Researchers. The annual list uses both quantitative and qualitative analysis to identify individuals from across the globe who have demonstrated significant and broad influence on their chosen field or fields of research.
The list is based on the Web of Science citation index, drawing from papers that rank in the top 1% by citations. Citations refer to how often a published research paper is included as a reference by other investigators in their work, which is a measure of that research paper’s reach and influence.
The 2022 list includes St. Jude scientists working in 8 departments and research centers.
Geoffrey Neale, Ph.D., is the Director of the Hartwell Center for Biotechnology at St. Jude. The Hartwell Center provides St. Jude researchers with advanced high-throughput biotechnology resources. These include a variety of genome sequencing approaches (whole genome sequencing, RNA-seq, ChIP-seq, etc.), DNA genotyping analysis, functional genomics and more. Virtually all research laboratories at St. Jude use at least one of the Center’s services.
“Scientific discovery is a collaborative endeavor,” Neale said. “It is very rewarding to know our contributions are highly valued, and that they inspire new ideas and additional investigations by other scientists around the world. It is an honor to be ranked among the most highly cited scientists. This recognition affirms our research plays a significant role in advancing impactful biomedical discoveries.”
The list is compiled by the Institute for Scientific Information at Clarivate, a London-based firm that publishes the list. In 2022, Clarivate partnered with the website Retraction Watch for a more qualitative analysis of the list.
St. Jude scientists on the 2022 Highly Cited Researchers list:
- Brian Abraham, Ph.D., Computational Biology (Molecular Biology and Genetics)
- Kelly Caudle, Pharm.D., Ph.D., Pharmaceutical Sciences (Pharmacology and Toxicology)
- Kristine Crews, Pharm.D., Pharmaceutical Sciences (Pharmacology and Toxicology)
- Hongbo Chi, Ph.D., Immunology (Immunology)
- William E. Evans, Pharm.D., Pharmaceutical Sciences, emeritus (Cross Field)
- Douglas Green, Ph.D., Immunology chair (Immunology, Molecular Biology and Genetics)
- Thirumala-Devi Kanneganti, Ph.D., Immunology vice-chair (Immunology)
- Charles Mullighan, M.B.B.S. (Hons), M.D., Pathology (Cross Field)
- Geoffrey Neale, Ph.D., Hartwell Center, (Immunology)
- Ching-Hon Pui, M.D., Oncology chair (Cross Field)
- Mary Relling, Pharm.D., Pharmaceutical Sciences (Pharmacology and Toxicology)
- J. Paul Taylor, M.D., Ph.D., Cell and Molecular Biology chair (Cross Field)
- Shengdar Tsai, Ph.D., Hematology (Biology and Biochemistry)
- Peter Vogel, D.V.M., Ph.D., Advanced Histology Core (Immunology)
The 2022 list includes 7,225 researchers from 69 countries and regions, 38.3% of which hail from institutions in the United States.
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease, and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit stjude.org, read St. Jude Progress blog, and follow St. Jude on social media at @stjuderesearch.